NEUROBLASTOMA UK

Registered charity 326385 · accounts filings on the Charity Commission register · also known as THE NEUROBLASTOMA SOCIETY · also registered in Scotland as SC053101 (OSCR)

Neuroblastoma UK raises money to fund scientific research into the causes of neuroblastoma (a cancer affecting mainly young children) and improved treatments. It also provides support and advice to parents and others affected by the disease.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income

£303k

Latest spending

£1.2m

Registered

1983

Accounts read

FY2024

Financial health, per its FY2024 accounts

The accounts state that unrestricted reserves fell to a negative £295,947 at year-end, a significant decline from the previous year's surplus of £586,048. This deficit resulted from total expenditure of £1,185,345 significantly exceeding total income of £303,350. Despite the negative net assets, the charity holds current assets of £1,376,198, including £1,250,792 in investments, which the trustees consider sufficient to meet liabilities.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves position: below the charity's own stated reserves policy (held: £-296k; policy: adequate reserves for known and potential liabilities and commitments)

“The balance held as unrestricted reserves at 31 December, 2024 was negative £295,947”

Per its FY2024 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Public fundraising profile: JustGiving — Neuroblastoma UK (matched by registered charity number).

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/12/2023)

Total income

£665k

Total spending

£151k

Cost of raising funds

£7k

Reserves (reported)

£586k

Employees

Reported reserves equal ~46.5 months of spending — in the top quarter for charities its size (median 7.0 months; benchmarks).

Per its annual return, largest income source: Donations and legacies (55% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 1.0% of total income — below the median for charities its size (2.9%) (benchmarks).

Register events

Received assets from another charity (08/04/2019) — per the register’s event history; asset transfers typically record mergers or reorganisations.

Trustees · trustee networks

Clair Cliff
DR Katherine Wheeler
Dr MARTIN ELLIOTT · trustee of 1 other charity
Dr Rebecca Louise Van Goethem
Faye Watts
Janet Elizabeth Davies
Jonathan Anderson
MALCOLM HUGH DEAN
PROFESSOR DEBORAH ANNE TWEDDLE
Ruby Charlotte Dickens
STEPHEN MICHAEL SMITH
Victoria Eadington · trustee of 1 other charity
Zara Aitchison

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year end	Income	Spending
31/12/2024	£303k	£1.2m
31/12/2023	£665k	£151k
31/12/2022	£268k	£819k
31/12/2021	£417k	£122k
31/12/2020	£341k	£441k

Common questions

Is NEUROBLASTOMA UK financially healthy?

Per its FY2024 accounts: The accounts state that unrestricted reserves fell to a negative £295,947 at year-end, a significant decline from the previous year's surplus of £586,048. This deficit resulted from total expenditure of £1,185,345 significantly exceeding total income of £303,350. Despite the negative net assets, the charity holds current assets of £1,376,198, including £1,250,792 in investments, which the trustees consider sufficient to meet liabilities. Its FY2024 accounts were independently examined.

Who funds NEUROBLASTOMA UK?

Funders whose own accounts filings name NEUROBLASTOMA UK as a grant recipient include THE IMP TRUST, Solving Kids' Cancer UK, ROBERT LUFF FOUNDATION LIMITED, THE GROCERS' CHARITY.

Known funders

Grants to this charity found in funders’ own accounts filings.

Funder	Year	Amount	Purpose (as stated by the funder)
THE IMP TRUST	FY2025	£139k
Solving Kids' Cancer UK	FY2025	£125k	Co-funding UK sites for the SIOPEN High-Risk Neuroblastoma 2 Trial
ROBERT LUFF FOUNDATION LIMITED	FY2025	£20k
THE GROCERS' CHARITY	FY2025	£5k	Health

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Funder	Similar charities funded	Amount to them
CBRE UK CHARITABLE TRUST	3	£3k
THE HOBSON CHARITY LIMITED	2	£33k
THE GEORGE CADBURY TRUST (GEORGE HENRY T AND LAURENCE J CADBURY SECTIONS)	2	£22k
THE CATHERINE COOKSON CHARITABLE TRUST	2	£20k
SANDRA CHARITABLE TRUST	2	£17k
THE HISCOX FOUNDATION	2	£3k
THE OAKDALE TRUST	2	£3k
The Squire Patton Boggs Charitable Trust	2	£700

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with Solving Kids' Cancer UK.

Solving Kids' Cancer UK income £2.9m
Children's Cancer North income £947k
CHILDREN WITH CANCER UK income £17.8m
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP income £5.5m
BRAIN TUMOUR RESEARCH income £8.7m
SARCOMA UK income £4.6m

Side by side with its peers

Charity	Income	Top pay band	Staff >£60k	Reserves vs policy	Fundraising cost	Going concern
NEUROBLASTOMA UK	£303k	—	0	below	—	no doubt
Solving Kids' Cancer UK FY2025	£2.9m	—	—	unclear	—	no doubt
Children's Cancer North FY2024	£947k	—	0	unclear	—	no doubt
CHILDREN WITH CANCER UK FY2024	£17.8m	£130,001 - £140,000	—	unclear	20.0%	no doubt
THE CHILDREN'S CANCER AND LEUKAEMIA GROUP FY2025	£5.5m	—	—	below	—	no doubt
BRAIN TUMOUR RESEARCH FY2025	£8.7m	—	—	unclear	—	no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.